Your session is about to expire
← Back to Search
External Beam Radiation Therapy for Prostate Cancer
Study Summary
This trial is comparing two ways of doing radiation therapy for prostate cancer to see which is more effective.
- Prostate Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 3 trial • 926 Patients • NCT01414608Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
If I enroll, am I allowed to participate in this clinical research?
"Prostate cancer patients aged 18 to 120 are encouraged to apply for this trial. Key requirements for applicants include: being in stages T1c to T2b, having no regional or distant metastases, no prior performance issues, and an American Urological Association voiding symptom score of 15 or lower."
Has EBRT been cleared by the FDA for cancer treatments?
"While not without its risks, external beam radiation therapy has been shown to be effective and safe in multiple rounds of clinical trials."
Are individuals needed for this experiment at present?
"This particular clinical trial, which was posted on June 1st 2003 and last updated on November 2nd 2021, is not currently recruiting patients. Although, there are 1352 other trials that are recruiting patients."
Could elderly patients over the age of 70 still benefit from this clinical trial?
"This trial is open to patients aged 18 and up, with a maximum age limit of 120 years old."
Share this study with friends
Copy Link
Messenger